Dr Vanessa Bonazzi
This person does not currently hold a position at QUT.
Personal details
Research field
Medical Biochemistry and Metabolomics, Medical Microbiology
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008
Qualifications
- PhD (Institut Curie Universite Paris VII)
Publications
- Packer, L., Geng, X., Bonazzi, V., Ju, R., Mahon, C., Cummings, M., Stephenson, S. & Pollock, P. (2017). PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2-mutant endometrial cancers. Molecular Cancer Therapeutics, 16(4), 637–648. https://eprints.qut.edu.au/104730
- Stark, M., Tom, L., Boyle, G., Bonazzi, V., Soyer, H., Herington, A., Pollock, P. & Hayward, N. (2016). The 'Melanoma-enriched' microRNA miR-4731-5p acts as a tumour suppressor. OncoTarget, 7(31), 49677–49687. https://eprints.qut.edu.au/101191
- Stark, M., Bonazzi, V., Boyle, G., Palmer, J., Symmons, J., Lanagan, C., Schmidt, C., Herington, A., Ballotti, R., Pollock, P. & Hayward, N. (2015). miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma. OncoTarget, 6(19), 17753–17763. https://eprints.qut.edu.au/90803
- Stark, M., Woods, S., Gartside, M., Bonazzi, V., Dutton-Regester, K., Aoude, L., Chow, D., Sereduk, C., Niemi, N., Tang, N., Ellis, J., Reid, J., Zismann, V., Tyagi, S., Muzny, D., Newsham, I., Wu, Y., Palmer, J., Pollak, T., Youngkin, D., Brooks, B., Lanagan, C., Schmidt, C., Kobe, B., MacKeigan, J., Yin, H., Brown, K., Gibbs, R., Trent, J. & Hayward, N. (2012). Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nature Genetics, 44(2), 165–169. https://eprints.qut.edu.au/107287
- Boyle, G., Woods, S., Bonazzi, V., Stark, M., Hacker, E., Aoude, L., Dutton-Regester, K., Cook, A., Sturm, R. & Hayward, N. (2011). Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell and Melanoma Research, 24(3), 525–537. https://eprints.qut.edu.au/47505
- Dry, J., Pavey, S., Pratilas, C., Harbron, C., Runswick, S., Hodgson, D., Chresta, C., McCormack, R., Byrne, N., Cockerill, M., Graham, A., Beran, G., Cassidy, A., Haggerty, C., Brown, H., Ellison, G., Dering, J., Taylor, B., Stark, M., Bonazzi, V., Ravishankar, S., Packer, L., Xing, F., Solit, D., Finn, R., Rosen, N., Hayward, N., French, T. & Smith, P. (2010). Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244). Cancer Research, 70(6), 2264–2273. https://eprints.qut.edu.au/76310
QUT ePrints
To find publications by Vanessa, visit QUT ePrints, the University's research repository.